Evidence map›Paper›PMID 38324233›Full record

ArticleAnalytical sciences : the international journal of the Japan Society for Analytical Chemistry2024

PLA/CS-ZnO bionanocomposite for rapid catalytic reduction of nitrophenol compounds as a heterogeneous nanocatalyst.

Ali Roostaie, Reza Haddad, Mehdi Haji Abdolrasouli

Abstract read
PubMed Publisher
In one paragraph

Article in Analytical sciences : the international journal of the Japan Society for Analytical Chemistry, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.3field-weighted citation impact, top 54% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Ali RoostaieDepartment of Police Equipment and Technologies, Policing Sciences and Social Studies Institute, Tehran, Iran. ali.roostaie1@gmail.com.
Reza HaddadDepartment of Police Equipment and Technologies, Policing Sciences and Social Studies Institute, Tehran, Iran.
Mehdi Haji AbdolrasouliDepartment of Chemical Engineering, Faculty of Chemical and Petroleum Engineering, University of Hormozgan, Bandar-Abbas, Iran.
Hormozgan University · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In this research, a high efficiency and environmentally friendly method to reduce nitrophenol compounds such as 4-nitrophenol (4-NP), 2,4,6-trinitrophenol (2,4,6-TNP) and 2,4-dinitrophenol (2,4-DNP) was used in the presence of poly(lactic acid)/chitosan-ZnO ( PLA/CS-ZnO) bionanocomposite. Using FT-IR, SEM, XRD and UV-Vis techniques, PLA/CS-ZnO bionanocomposite was identified after synthesis. Also, the mechanical properties of the bionanocomposite were investigated using the stress-strain curve. The mentioned bionanocomposite showed a very good efficiency in reducing nitrophenol compounds to aminophenolic compounds, so that under optimal conditions, 100% conversion and selectivity in the reduction of 4-NP, 2,4,6-TNP and 2,4-DNP to 4-aminophenol (4-AP), 2,4,6-triaminophenol (2,4,6-TAP) and 2,4-diaminophenol (2,4-DAP) were observed. UV-Vis absorption spectrum at different times were used to evaluate the progress of the reaction. Furthermore, after the reaction, PLA/CS-ZnO was recovered and used for the next cycle. The results showed that the bionanocomposite can perform ten consecutive cycles without a significant decrease in efficiency. The comparison of catalytic activity with other catalysts showed that the bionanocomposite synthesized in the present research has a higher efficiency in reduction of nitrophenol compounds.

Indexed as

AminophenolsChitosanNitrophenol compoundsPolylactic acidReduction

Identifiers

PMID38324233
OpenAlexW4391613300

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.